Ulcerative Colitis: SAR441566 Study

We are investigating the effects of SAR441566 in adults with moderate-to-severe ulcerative colitis. The study aims to see if different doses can help achieve remission and improve overall health.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Sar441566

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Division of Gastroenterology and Hepatology
Graz, Austria
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Clinic for Internal Medicine I, Gastroenterology-Hepatology, Nephrology, Metabolism and Diabetology
Salzburg, Austria
Medical University Of Vienna
Clinical Department for Gastroenterology and Hepatology
Vienna, Austria

Sponsor: Sanofi-Aventis Recherche & Developpement
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.